Clinical Trial Update: Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety and tolerability of Copaiba in patients with oral cancer undergoing radiotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• Copaiba (copaiba oil)

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Head and Neck Neoplasms, Mucositis Oral | Phase 1 | Status: ACTIVE_NOT_RECRUITING